These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21747954)

  • 1. Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice.
    Meng T; Kolpe AB; Kiener TK; Chow VT; Kwang J
    PLoS One; 2011; 6(7):e21757. PubMed ID: 21747954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
    Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J
    Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in mice.
    Premanand B; Prabakaran M; Kiener TK; Kwang J
    PLoS One; 2013; 8(2):e55536. PubMed ID: 23390538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Display of enterovirus 71 VP1 on baculovirus as a type II transmembrane protein elicits protective B and T cell responses in immunized mice.
    Kolpe AB; Kiener TK; Grotenbreg GM; Kwang J
    Virus Res; 2012 Sep; 168(1-2):64-72. PubMed ID: 22728446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological evaluation and comparison of different EV71 vaccine candidates.
    Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
    Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.
    Ku Z; Ye X; Huang X; Cai Y; Liu Q; Li Y; Su Z; Huang Z
    PLoS One; 2013; 8(2):e57601. PubMed ID: 23451250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
    Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
    J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.
    Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM
    Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development.
    Gong M; Zhu H; Zhou J; Yang C; Feng J; Huang X; Ji G; Xu H; Zhu P
    J Virol; 2014 Jun; 88(11):6444-52. PubMed ID: 24672036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
    Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
    Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment.
    Ch'ng WC; Stanbridge EJ; Ong KC; Wong KT; Yusoff K; Shafee N
    J Med Virol; 2011 Oct; 83(10):1783-91. PubMed ID: 21837796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.
    Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z
    Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.
    Foo DG; Alonso S; Phoon MC; Ramachandran NP; Chow VT; Poh CL
    Virus Res; 2007 Apr; 125(1):61-8. PubMed ID: 17222936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
    Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
    PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice.
    Wang M; Jiang S; Wang Y
    Biochem Biophys Res Commun; 2013 Jan; 430(1):387-93. PubMed ID: 23159634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.